Stay updated on REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2. This appears to be a version label update rather than a change to study content or site navigation.SummaryDifference0.0%

- Check19 days agoChange DetectedMinor site revision update from v3.4.0 to v3.4.1 with no impact on the study page content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check33 days agoChange DetectedGlossary visibility controls (Show glossary / Hide glossary) were added, wording tweaks include Last Update Submitted that Met QC Criteria and No FEAR Act Data, and the revision version was bumped to v3.4.0 (from v3.3.4).SummaryDifference0.2%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No user-visible changes to the Study Details page were observed.SummaryDifference0.0%

- Check69 days agoChange DetectedA new Locations section with listed study sites in the United States, Canada, and Hungary (including Bekes County and Hajdú-Bihar) was added, and the page revision tag was updated to v3.3.3.SummaryDifference2%

- Check90 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2. No visible changes to the page content.SummaryDifference0.0%

Stay in the know with updates to REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN3500 Efficacy/Safety/PK in Atopic Dermatitis Clinical Trial page.